These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27958694)

  • 1. Transcatheter edge-to-edge mitral valve repair in heart failure.
    Orban M; Orban M; Braun D; Nabauer M; Massberg S; Hausleiter J
    Minerva Cardioangiol; 2017 Jun; 65(3):314-320. PubMed ID: 27958694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in patient selection and devices for transcatheter edge-to-edge mitral valve repair in heart failure.
    Orban M; Lüsebrink E; Braun D; Stocker TJ; Bagaev E; Hagl C; Näbauer M; Massberg S; Orban M; Hausleiter J
    Expert Rev Med Devices; 2020 Feb; 17(2):93-102. PubMed ID: 31923376
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of Cardiovascular Events and Structural and Functional Remodeling of the Heart in Patients With Severe Mitral Regurgitation of Various Genesis Underwent Transcatheter Mitral Valve Repair "Edge-To-Edge".
    Makeev MI; Saidova MA; Safiullina AA; Komlev AE; Kuchin IV; Kantemirova MM; Imaev TE
    Kardiologiia; 2024 Sep; 64(9):3-15. PubMed ID: 39392264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT Trial.
    Asch FM; Grayburn PA; Siegel RJ; Kar S; Lim DS; Zaroff JG; Mishell JM; Whisenant B; Mack MJ; Lindenfeld J; Abraham WT; Stone GW; Weissman NJ;
    J Am Coll Cardiol; 2019 Dec; 74(24):2969-2979. PubMed ID: 31574303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitral valve interventions in heart failure.
    Lavall D; Hagendorff A; Schirmer SH; Böhm M; Borger MA; Laufs U
    ESC Heart Fail; 2018 Aug; 5(4):552-561. PubMed ID: 29676043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for long-term survival after transcatheter edge-to-edge mitral valve repair.
    Orban M; Orban M; Lesevic H; Braun D; Deseive S; Sonne C; Hutterer L; Grebmer C; Khandoga A; Pache J; Mehilli J; Schunkert H; Kastrati A; Hagl C; Bauer A; Massberg S; Boekstegers P; Nabauer M; Ott I; Hausleiter J
    J Interv Cardiol; 2017 Jun; 30(3):226-233. PubMed ID: 28370526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Hemodynamic Improvement after Transcatheter Mitral Valve Repair.
    Lavall D; Mehrer M; Schirmer SH; Reil JC; Wagenpfeil S; Böhm M; Laufs U
    J Am Soc Echocardiogr; 2018 Sep; 31(9):1013-1020. PubMed ID: 30176994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of MitraClip™ therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry.
    Geis NA; Puls M; Lubos E; Zuern CS; Franke J; Schueler R; von Bardeleben RS; Boekstegers P; Ouarrak T; Zahn R; Ince H; Senges J; Katus HA; Bekeredjian R
    Eur J Heart Fail; 2018 Mar; 20(3):598-608. PubMed ID: 28834079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
    Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    Arnold SV; Chinnakondepalli KM; Spertus JA; Magnuson EA; Baron SJ; Kar S; Lim DS; Mishell JM; Abraham WT; Lindenfeld JA; Mack MJ; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2019 May; 73(17):2123-2132. PubMed ID: 30894288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.
    Lim DS; Reynolds MR; Feldman T; Kar S; Herrmann HC; Wang A; Whitlow PL; Gray WA; Grayburn P; Mack MJ; Glower DD
    J Am Coll Cardiol; 2014 Jul; 64(2):182-92. PubMed ID: 24184254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials.
    Grayburn PA; Sannino A; Packer M
    JACC Cardiovasc Imaging; 2019 Feb; 12(2):353-362. PubMed ID: 30553663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Functional Mitral Regurgitation with Transcatheter Edge-to-Edge Repair.
    Huded C; Kapadia S
    Interv Cardiol Clin; 2019 Jul; 8(3):235-243. PubMed ID: 31078179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of right heart function on outcome in patients with functional mitral regurgitation and chronic heart failure undergoing percutaneous edge-to-edge-repair.
    Osteresch R; Diehl K; Kühl M; Fiehn E; Schmucker J; Backhaus T; Fach A; Wienbergen H; Hambrecht R
    J Interv Cardiol; 2018 Dec; 31(6):916-924. PubMed ID: 30397932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: mid-term results of a single-centre experience†.
    De Bonis M; Taramasso M; Lapenna E; Denti P; La Canna G; Buzzatti N; Pappalardo F; Di Giannuario G; Cioni M; Giacomini A; Alfieri O
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):255-62. PubMed ID: 25669650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies: Do They Have a Role in Advanced Heart Failure with Reduced Ejection Fraction?
    Pienta MJ; Romano MA
    Heart Fail Clin; 2024 Oct; 20(4):437-444. PubMed ID: 39216928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Mitral Valve Repair With MitraClip for Symptomatic Functional Mitral Valve Regurgitation.
    Mendirichaga R; Singh V; Blumer V; Rivera M; Rodriguez AP; Cohen MG; O'Neill WW; Elmariah S
    Am J Cardiol; 2017 Aug; 120(4):708-715. PubMed ID: 28645469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure.
    Neuss M; Schau T; Schoepp M; Seifert M; Hölschermann F; Meyhöfer J; Butter C
    Eur J Heart Fail; 2013 Jul; 15(7):786-95. PubMed ID: 23325017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge-to-edge mitral valve repair.
    Orban M; Braun D; Orban M; Grebmer C; Sibbing D; Thaler R; Tittus J; Wimbauer F; Lesevic H; Sonne C; Mehilli J; Ott I; Näbauer M; Massberg S; Boekstegers P; Hausleiter J
    J Interv Cardiol; 2015 Apr; 28(2):164-71. PubMed ID: 25858050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.